Test Price
1,100 AED✅ Home Collection Available
Maternally Inherited Cardiomyopathy (MICM) Mutation Detection Test in UAE
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 accredited PCR‑Sanger sequencing – definitive detection of maternally inherited mitochondrial DNA mutations.
Premium Logistics: Hospital‑grade refrigerated home collection (8 AM – 11 PM) with validated cold‑chain management. VIP mobile phlebotomy ensures sample integrity from doorstep to lab.
Clinical Guidance: Complimentary telephonic post‑test genetic counseling with a consultant medical geneticist. Interpretation aligned with ICD‑10‑CM codes I42.8, E88.40, Z15.89.
Insurance: Direct billing verification via WhatsApp. We handle approvals for most major UAE networks. WhatsApp: +971 54 548 8731
Test Overview & Methodology
Maternally inherited cardiomyopathy arises from mitochondrial genome mutations passed exclusively from mother to child; this advanced test screens the entire mitochondrial DNA with PCR amplification and Sanger sequencing, identifying pathogenic variants linked to hypertrophic, dilated, or restrictive cardiomyopathies.
| Feature | Our Test – MICM Panel | Closest Alternative – Single Gene Screen |
|---|---|---|
| Precision | 99.9% diagnostic sensitivity; full mtDNA coverage | <85% sensitivity; limited to hotspots |
| Methodology | PCR + Bidirectional Sanger Sequencing (ISO 9001:2015) | Restriction fragment analysis or outdated MLPA |
| Turnaround | 10 working days from sample receipt | 14–21 days |
| Clinical Validation | DHA recognized, compliant with PDPL and Federal Law 2/2019 | Variable; often lacks UAE genetic testing license |
Physician Insight & Safety Protocols
“A positive MICM result must always be interpreted alongside cardiac imaging, family history, and biochemical markers. This test does not predict disease severity but confirms a maternal lineage risk – early cardiology follow‑up is essential. I urge patients to discuss reproductive options and cascade screening with their families under the protection of UAE data protection laws.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory Note on Medication
Do not discontinue or adjust any prescribed cardiac or metabolic medication without consulting your treating physician. Genetic results alone do not replace clinical monitoring; abrupt cessation of beta‑blockers, anti‑arrhythmics, or mitochondrial supplements can trigger acute decompensation.
Safety Exclusion Criteria & Emergency Red Flags
- Acute myocardial infarction or unstable angina within the past 7 days – sample collection deferred.
- Known mitochondrial crisis (acute lactic acidosis, seizures, stroke‑like episodes) – prior emergency stabilisation required.
- Minors: parental/guardian written consent is mandatory in accordance with DHA regulations; test cannot proceed without it.
- Seek immediate emergency care if you experience: sudden chest pain, severe shortness of breath, syncope, or rapid weight gain with leg swelling – these may indicate acute cardiac failure unrelated to the test.
Patient FAQ & Clinical Guidance
1. How does the MICM test differ from a standard cardiac genetic panel?
A: A standard cardiac panel often misses mitochondrial mutations, while our MICM test directly sequences the entire mitochondrial genome with 99.9% sensitivity, pinpointing maternally inherited variants linked to cardiomyopathy. Results take 10 working days and are interpreted against ICD‑10‑CM codes I42.8, E88.40, Z15.89.
2. Is home sample collection safe and cold‑chain compliant for this test?
A: Yes, our ISO 9001:2015‑certified phlebotomists use validated refrigerated transport (2–8°C) in sealed coolers, preserving EDTA‑whole blood integrity for up to 36 hours. VIP mobile collection is available across Dubai, Abu Dhabi, and all emirates from 8 AM to 11 PM.
3. Will my insurance cover the MICM mutation detection?
A: Most UAE plans cover genetic testing for cardiomyopathy when prescribed by a cardiologist or geneticist; we provide direct billing verification via WhatsApp (+971545488731) and submit pre‑authorization under ICD‑10‑CM codes I42.8 and Z15.89. Our team handles claims for major networks like Daman, AXA, and Nextcare.
UAE Regulatory & Data Privacy Adherence
This test and laboratory operations follow the regulatory framework of the Dubai Health Authority (DHA), including:
- Data Privacy: Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – ensuring your genetic data is processed lawfully and securely.
- Health Information: Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – governing electronic health data exchange.
- Medical Liability: Federal Decree-Law No. 4 of 2016 on Medical Liability – establishing patient consent and clinical safety standards.
DHA Facility License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab: DNA Labs UAE
Clinical & Logistical Metadata
| Test Name | Maternally Inherited Cardiomyopathy (MICM) Mutation Detection |
| Price (AED) | 1100 AED |
| Turnaround Time | 10 working days from sample receipt |
| Sample Type / Matrix | EDTA whole blood (peripheral) |
| Methodology Used | PCR + Bidirectional Sanger Sequencing (ISO 9001:2015) |
| ICD-10-CM Code | I42.8, E88.40, Z15.89 |
| LOINC Code | 83092-7 |
| DHA Facility License & Lab Address | DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians